Document is current
Any future updates will be listed below
-
Authors
Wintergerst, Maximilian W. M.
Merten, Nicholas R.
Berger, Moritz
Dysli, Chantal
Terheyden, Jan H.
Poletti, Enea
Holz, Frank G.
Schäfer, Valentin S.
Schmid, Matthias
Ach, Thomas
Finger, Robert P.
-
Funding
Funding for this research was provided by:
BONFOR GEROK Program, Faculty of Medicine, University of Bonn (O-137.0028)
Else Kroener-Fresenius Foundation and the German Scholars Organization (EKFS/GSO 16)
Universitätsklinikum Bonn
- License Information
-
More Information
Article History
Received: 9 January 2022
Accepted: 4 August 2022
First Online: 29 August 2022
Competing interests
: Maximilian W.M. Wintergerst: DigiSight Technologies: travel grant, D-EYE Srl: imaging devices, Heine Optotechnik GmbH: research funding, imaging devices, travel reimbursements, consultant; Eyenuk, Inc: free trial analysis; ASKIN & CO GmbH: travel reimbursement, honoraria; Berlin-Chemie AG: grant, travel reimbursements; Imaging devices were provided by Heidelberg Engineering, Optos, Carl Zeiss Meditec, and CenterVue; Nicholas R. Merten: No financial disclosures; Moritz Berger: No financial disclosures; Chantal Dysli: No financial disclosures; Jan H. Terheyden: Imaging devices were provided by Heidelberg Engineering, Optos, Carl Zeiss Meditec, and CenterVue; Enea Poletti: Employment: Centervue S.p.A.; Frank G. Holz: Research Grant Support: Acucela, Allergan, Apellis, Bayer, Bioeq/Formycon, CenterVue, Ellex, Roche/Genentech, Geuder, Kanghong, NightStarx, Novartis, Optos, Zeiss; Consultant: Acucela, Aerie, Allergan, Apellis, Bayer, Boehringer-Ingelheim, ivericbio, Roche/Genentech, Geuder, Grayburg Vision, ivericbio, LinBioscience, Kanghong, Novartis, Pixium Vision, Oxurion, Stealth BioTherapeutics, Zeiss; Valentin S. Schäfer: No financial disclosures; Matthias Schmid: No financial disclosures; Thomas Ach: Research Grant Support: Novartis; Lecture fee: Novartis, Heidelberg Engineering; Advisory Board: Roche; Invest: Macregen; Robert P. Finger: funding was provided by Else Kroener-Fresenius Foundation and the German Scholars Organization (EKFS/GSO 16); financial support: Novartis, Heidelberg Engineering, Optos, Carl Zeiss Meditec, and CenterVue. Consultant: Bayer, Novartis, Roche/Genentech, Boehringer-Ingelheim, Opthea, Santhera, Inositec, Alimera, Allergan, Ellex.
